Hamada Masaaki, Sakurai Yoshihiko, Tanaka Ichiro
Department of Paediatrics, Yao Municipal Hospital, Osaka, Japan.
Department of Legal Medicine, Nara Medical University, Kashihara, Japan.
Asia Pac Allergy. 2025 Sep;15(3):208-211. doi: 10.5415/apallergy.0000000000000185. Epub 2025 Feb 5.
The treatment for acute food protein-induced enterocolitis syndrome (FPIES) has not been fully resolved. We investigated the efficacy of 5-HT receptor inhibitors and steroids in patients with recurrent vomiting during the oral food challenge test (OFC) for acute FPIES. Patients who met the diagnostic criteria of the international guidelines of acute FPIES and developed recurrent vomiting with the OFC were enrolled. Patients who had a single vomiting underwent infusion with normal saline. A 5-HT receptor inhibitor was administered intravenously when recurrent vomiting appeared with lethargy and/or pallor. If the patient continued to develop persistent symptoms, additional steroids were administered intravenously. This study examined the rate of OFCs in which the administration of a single 5HT inhibitor was insufficient to improve gastrointestinal symptoms, requiring the additional administration of steroids. A total of 20 OFCs were included; 2 treated with infusion therapy, 9 OFCs treated with 5-HT receptor inhibitor, and 9 OFCs treated with 5-HT receptor inhibitors and steroids. Nine OFCs treated with a single 5-HT receptor inhibitor were effective, with only 2 episodes of vomiting observed before administration, and none after treatment. In the remaining 9 OFCs, steroids were additionally administered due to persistent symptoms. Five of 7 OFCs with persistent vomiting improved, and all 7 OFCs with persistent lethargy improved. This study revealed that in OFCs performed due to acute FPIES leading to recurrent vomiting, monotherapy with 5-HT receptor inhibitors was insufficient in half of the OFCs, suggesting that combination therapy with 5-HT receptor inhibitors and steroids should be considered for severe OFCs.
急性食物蛋白诱导的小肠结肠炎综合征(FPIES)的治疗方法尚未完全明确。我们研究了5-羟色胺(5-HT)受体抑制剂和类固醇对急性FPIES口服食物激发试验(OFC)期间反复呕吐患者的疗效。纳入符合急性FPIES国际指南诊断标准且在OFC期间出现反复呕吐的患者。仅有单次呕吐的患者接受生理盐水输注。当反复呕吐伴有嗜睡和/或面色苍白时,静脉注射5-HT受体抑制剂。如果患者持续出现症状,则静脉注射额外的类固醇。本研究考察了单次使用5-HT抑制剂不足以改善胃肠道症状而需要额外使用类固醇的OFC发生率。总共纳入了20次OFC;2次采用输注治疗,9次采用5-HT受体抑制剂治疗,9次采用5-HT受体抑制剂和类固醇联合治疗。9次采用单一5-HT受体抑制剂治疗的OFC有效,给药前仅观察到2次呕吐发作,治疗后无呕吐发作。在其余9次OFC中,由于症状持续而额外使用了类固醇。7次持续呕吐的OFC中有5次症状改善,所有7次持续嗜睡的OFC均有改善。本研究表明,在因急性FPIES导致反复呕吐而进行的OFC中,半数OFC采用5-HT受体抑制剂单一疗法是不够的,这表明对于严重的OFC应考虑5-HT受体抑制剂与类固醇联合治疗。